Precision medicine in Type 2 Diabetes: Targeting SGLT2-inhibitor Treatment For Kidney Protection

Thijs T Jansz, Katherine G Young, Rhian Hopkins, Andrew P McGovern, Beverley M Shields, Andrew T Hattersley, Angus G Jones, Ewan R Pearson, Richard A Oram, John M Dennis MASTERMIND Consortium
doi: https://doi.org/10.1101/2024.09.01.24312905

Data Availability

CPRD data are available by application to the CPRD Independent Scientific Advisory Committee. All R code to reproduce the analyses in this paper is available at https://github.com/Exeter-Diabetes/CPRD-Thijs-SGLT2-KF-scripts

https://github.com/Exeter-Diabetes/CPRD-Thijs-SGLT2-KF-scripts

https://github.com/Exeter-Diabetes/CPRD-Codelists

https://github.com/Exeter-Diabetes/CPRD-Cohort-scripts

Back to top
Posted September 02, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Precision medicine in Type 2 Diabetes: Targeting SGLT2-inhibitor Treatment For Kidney Protection
Thijs T Jansz, Katherine G Young, Rhian Hopkins, Andrew P McGovern, Beverley M Shields, Andrew T Hattersley, Angus G Jones, Ewan R Pearson, Richard A Oram, John M Dennis
medRxiv 2024.09.01.24312905; doi: https://doi.org/10.1101/2024.09.01.24312905
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area